• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一些决定与大鼠肝脏细胞色素P-450相互作用的苯海拉明类似物的结构特征。

Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450.

作者信息

Rekka E, Timmermann H, Bast A

机构信息

Department of Pharmacochemistry, Faculty of Chemistry, Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Agents Actions. 1989 Apr;27(1-2):184-7. doi: 10.1007/BF02222234.

DOI:10.1007/BF02222234
PMID:2750591
Abstract

The aim of this study was to define the structural characteristics in a series of 21 analogues of the anti-histaminergic drug diphenhydramine which are important for the interaction with cytochrome P-450. The compounds gave substrate (type I) binding spectra with rat hepatic microsomal cytochrome P-450. The main findings were: (1) two phenyl rings are needed for strong binding: saturation or elimination of one ring, or restriction of two phenyls with a two-carbon bridge results in a decrease of binding, (2) substitution on one or both aromatic rings has only a small influence on binding, (3) an amine nitrogen contributes to better binding; decrease or absence of basicity weakens binding, and (4) a chain of 4 to 7 atoms connecting the basic centre with the aromatic part is needed; reduction of the chain length, or restriction of it to a cyclic structure causes decrease or loss of binding ability.

摘要

本研究的目的是确定抗组胺药苯海拉明的21种类似物的结构特征,这些特征对于与细胞色素P - 450的相互作用很重要。这些化合物与大鼠肝微粒体细胞色素P - 450产生底物(I型)结合光谱。主要发现如下:(1)强烈结合需要两个苯环:一个环的饱和或消除,或用二碳桥限制两个苯环会导致结合力下降;(2)一个或两个芳香环上的取代对结合的影响很小;(3)胺氮有助于更好地结合;碱性降低或不存在会削弱结合;(4)需要一条由4至7个原子组成的链将碱性中心与芳香部分连接起来;链长度的缩短或将其限制为环状结构会导致结合能力下降或丧失。

相似文献

1
Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450.一些决定与大鼠肝脏细胞色素P-450相互作用的苯海拉明类似物的结构特征。
Agents Actions. 1989 Apr;27(1-2):184-7. doi: 10.1007/BF02222234.
2
Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues.细胞色素P-450与一系列苯海拉明类似物形成代谢中间复合物。
Agents Actions. 1990 Apr;30(1-2):161-5. doi: 10.1007/BF01969027.
3
Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels.苯海拉明及其他二苯基化合物对钠电流的抑制作用:与失活通道选择性结合的分子决定因素。
Mol Pharmacol. 2000 Jan;57(1):135-43.
4
The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation.2-正烷基苯并咪唑与大鼠肝微粒体细胞色素P-450的结合及单加氧作用抑制之间的关系
Biochem Pharmacol. 1982 Apr 1;31(7):1315-20. doi: 10.1016/0006-2952(82)90022-3.
5
[Interaction of 8-aza-16-oxasteroids with rat liver microsomal cytochrome P-450].
Biokhimiia. 1984 Apr;49(4):570-6.
6
Studies on the substrate-binding sites of liver microsomal cytochrome P-448.肝脏微粒体细胞色素P - 448底物结合位点的研究
Biochem J. 1982 Oct 1;207(1):51-6. doi: 10.1042/bj2070051.
7
One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.大鼠肝脏对丝裂霉素C的单电子还原作用:细胞色素P-450和NADPH-细胞色素P-450还原酶的作用
Xenobiotica. 1990 Sep;20(9):967-78. doi: 10.3109/00498259009046912.
8
The influence of side chain modifications of the heme moiety on prosthetic acceptance and function of rat hepatic cytochrome P-450 and tryptophan pyrrolase.血红素部分侧链修饰对大鼠肝细胞色素P-450和色氨酸吡咯酶辅基接受及功能的影响。
Arch Biochem Biophys. 1986 Apr;246(1):63-74. doi: 10.1016/0003-9861(86)90449-2.
9
Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450.某些潜在H2受体拮抗剂与大鼠肝脏P-450相互作用的结构特征鉴定
Chem Biol Interact. 1988;67(1-2):117-27. doi: 10.1016/0009-2797(88)90091-9.
10
Relation between the structure of benzphetamine analogues and their binding properties to cytochrome P-450 LM2.
Biochim Biophys Acta. 1985 Jun 10;829(2):253-61. doi: 10.1016/0167-4838(85)90195-5.

本文引用的文献

1
Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital.通过 d,l-普萘洛尔与 d,l-己巴比妥的相互作用说明底物与细胞色素 P-450 结合的竞争性抑制的计算。
Biochem Pharmacol. 1980 Mar 1;29(5):747-51. doi: 10.1016/0006-2952(80)90552-3.
2
Inhibitors of Cytochrome P-450s and their mechanism of action.细胞色素P-450抑制剂及其作用机制。
Drug Metab Rev. 1981;12(1):1-117. doi: 10.3109/03602538109011082.
3
Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat.
在大鼠体内单-N-去甲基邻甲苯海明(托非那辛)代谢过程中形成稳定的细胞色素P-450代谢中间复合物,导致邻甲苯海明代谢出现产物抑制现象。
Res Commun Chem Pathol Pharmacol. 1983 Jun;40(3):391-403.
4
Cytochrome P-455-nm complex formation in the metabolism of phenylalkylamines. VI. Structure--activity relationships in metabolic intermediary complex formation with a series of alpha-substituted 2-phenylethylamines and corresponding N-hydroxylamines.细胞色素P - 455 - 纳米复合物在苯烷基胺代谢中的形成。VI. 与一系列α-取代的2 - 苯乙胺及相应的N - 羟基胺形成代谢中间复合物的构效关系。
Drug Metab Dispos. 1982 Nov-Dec;10(6):700-5.
5
Functional group contributions to drug-receptor interactions.
J Med Chem. 1984 Dec;27(12):1648-57. doi: 10.1021/jm00378a021.
6
The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450.恶臭假单胞菌细胞色素P-450的2.6埃晶体结构。
J Biol Chem. 1985 Dec 25;260(30):16122-30.
7
Relation between the structure of benzphetamine analogues and their binding properties to cytochrome P-450 LM2.
Biochim Biophys Acta. 1985 Jun 10;829(2):253-61. doi: 10.1016/0167-4838(85)90195-5.
8
Dual ligand binding of pyridylalkanamides to microsomal cytochrome P-450.
Biochem Pharmacol. 1986 Jul 1;35(13):2233-40. doi: 10.1016/0006-2952(86)90597-6.
9
Defining the active site of cytochrome P-450: the crystal and molecular structure of an inhibitor, SKF-525A.细胞色素P-450活性位点的确定:抑制剂SKF-525A的晶体结构与分子结构
Carcinogenesis. 1987 Jul;8(7):881-7. doi: 10.1093/carcin/8.7.881.
10
Active site model of cytochrome P-450 LM2.细胞色素P-450 LM2的活性位点模型
Biochem Biophys Res Commun. 1988 Feb 15;150(3):996-1005. doi: 10.1016/0006-291x(88)90727-9.